Global Bromhexine Market Research Report 2023

Publisher Name :
Date: 07-Apr-2023
No. of pages: 113
Inquire Before Buying

Highlights

The global Bromhexine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Bromhexine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Bromhexine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Bromhexine include Sanofi Aventis, Teva, Boehringer Ingelheim, Novartis, Mylan, Sanyo Chemical Laboratroy, Sandoz, LGM Pharma and GSK, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bromhexine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bromhexine.

The Bromhexine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bromhexine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bromhexine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Sanofi Aventis

- Teva

- Boehringer Ingelheim

- Novartis

- Mylan

- Sanyo Chemical Laboratroy

- Sandoz

- LGM Pharma

- GSK

- Mayne Pharma

- Sigma-Aldrich

- Abbott

- Shanghai Sine Tianping Pharmaceutical

- Takeda

- Shanghai Xudong Haipu Pharmaceutical

- Jincheng Haisi Pharmaceutical

- Shanxi Powerdone Pharmaceutical

- Shanxi Powerdone Pharmaceutical

- Wanbangde Pharmaceutical Group

- Shijiazhuang No.4 Pharmaceutical

- Ma'AnShan BBCA Pharmaceutical

Segment by Type

- Oral

- Injection

Segment by Application

- Chronic Bronchitis

- Asthma

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Bromhexine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Bromhexine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Bromhexine Market Research Report 2023

Table of Contents
1 Bromhexine Market Overview
1.1 Product Overview and Scope of Bromhexine
1.2 Bromhexine Segment by Type
1.2.1 Global Bromhexine Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Injection
1.3 Bromhexine Segment by Application
1.3.1 Global Bromhexine Market Value by Application: (2023-2029)
1.3.2 Chronic Bronchitis
1.3.3 Asthma
1.3.4 Others
1.4 Global Bromhexine Market Size Estimates and Forecasts
1.4.1 Global Bromhexine Revenue 2018-2029
1.4.2 Global Bromhexine Sales 2018-2029
1.4.3 Global Bromhexine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bromhexine Market Competition by Manufacturers
2.1 Global Bromhexine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bromhexine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bromhexine Average Price by Manufacturers (2018-2023)
2.4 Global Bromhexine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bromhexine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bromhexine, Product Type & Application
2.7 Bromhexine Market Competitive Situation and Trends
2.7.1 Bromhexine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bromhexine Players Market Share by Revenue
2.7.3 Global Bromhexine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bromhexine Retrospective Market Scenario by Region
3.1 Global Bromhexine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bromhexine Global Bromhexine Sales by Region: 2018-2029
3.2.1 Global Bromhexine Sales by Region: 2018-2023
3.2.2 Global Bromhexine Sales by Region: 2024-2029
3.3 Global Bromhexine Global Bromhexine Revenue by Region: 2018-2029
3.3.1 Global Bromhexine Revenue by Region: 2018-2023
3.3.2 Global Bromhexine Revenue by Region: 2024-2029
3.4 North America Bromhexine Market Facts & Figures by Country
3.4.1 North America Bromhexine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bromhexine Sales by Country (2018-2029)
3.4.3 North America Bromhexine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bromhexine Market Facts & Figures by Country
3.5.1 Europe Bromhexine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bromhexine Sales by Country (2018-2029)
3.5.3 Europe Bromhexine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bromhexine Market Facts & Figures by Country
3.6.1 Asia Pacific Bromhexine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bromhexine Sales by Country (2018-2029)
3.6.3 Asia Pacific Bromhexine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bromhexine Market Facts & Figures by Country
3.7.1 Latin America Bromhexine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bromhexine Sales by Country (2018-2029)
3.7.3 Latin America Bromhexine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bromhexine Market Facts & Figures by Country
3.8.1 Middle East and Africa Bromhexine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bromhexine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bromhexine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bromhexine Sales by Type (2018-2029)
4.1.1 Global Bromhexine Sales by Type (2018-2023)
4.1.2 Global Bromhexine Sales by Type (2024-2029)
4.1.3 Global Bromhexine Sales Market Share by Type (2018-2029)
4.2 Global Bromhexine Revenue by Type (2018-2029)
4.2.1 Global Bromhexine Revenue by Type (2018-2023)
4.2.2 Global Bromhexine Revenue by Type (2024-2029)
4.2.3 Global Bromhexine Revenue Market Share by Type (2018-2029)
4.3 Global Bromhexine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bromhexine Sales by Application (2018-2029)
5.1.1 Global Bromhexine Sales by Application (2018-2023)
5.1.2 Global Bromhexine Sales by Application (2024-2029)
5.1.3 Global Bromhexine Sales Market Share by Application (2018-2029)
5.2 Global Bromhexine Revenue by Application (2018-2029)
5.2.1 Global Bromhexine Revenue by Application (2018-2023)
5.2.2 Global Bromhexine Revenue by Application (2024-2029)
5.2.3 Global Bromhexine Revenue Market Share by Application (2018-2029)
5.3 Global Bromhexine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi Aventis
6.1.1 Sanofi Aventis Corporation Information
6.1.2 Sanofi Aventis Description and Business Overview
6.1.3 Sanofi Aventis Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Aventis Bromhexine Product Portfolio
6.1.5 Sanofi Aventis Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Teva Bromhexine Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Bromhexine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Bromhexine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Bromhexine Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Sanyo Chemical Laboratroy
6.6.1 Sanyo Chemical Laboratroy Corporation Information
6.6.2 Sanyo Chemical Laboratroy Description and Business Overview
6.6.3 Sanyo Chemical Laboratroy Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sanyo Chemical Laboratroy Bromhexine Product Portfolio
6.6.5 Sanyo Chemical Laboratroy Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sandoz Bromhexine Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 LGM Pharma
6.8.1 LGM Pharma Corporation Information
6.8.2 LGM Pharma Description and Business Overview
6.8.3 LGM Pharma Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 LGM Pharma Bromhexine Product Portfolio
6.8.5 LGM Pharma Recent Developments/Updates
6.9 GSK
6.9.1 GSK Corporation Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GSK Bromhexine Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Mayne Pharma
6.10.1 Mayne Pharma Corporation Information
6.10.2 Mayne Pharma Description and Business Overview
6.10.3 Mayne Pharma Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mayne Pharma Bromhexine Product Portfolio
6.10.5 Mayne Pharma Recent Developments/Updates
6.11 Sigma-Aldrich
6.11.1 Sigma-Aldrich Corporation Information
6.11.2 Sigma-Aldrich Bromhexine Description and Business Overview
6.11.3 Sigma-Aldrich Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sigma-Aldrich Bromhexine Product Portfolio
6.11.5 Sigma-Aldrich Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Bromhexine Description and Business Overview
6.12.3 Abbott Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Abbott Bromhexine Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Shanghai Sine Tianping Pharmaceutical
6.13.1 Shanghai Sine Tianping Pharmaceutical Corporation Information
6.13.2 Shanghai Sine Tianping Pharmaceutical Bromhexine Description and Business Overview
6.13.3 Shanghai Sine Tianping Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shanghai Sine Tianping Pharmaceutical Bromhexine Product Portfolio
6.13.5 Shanghai Sine Tianping Pharmaceutical Recent Developments/Updates
6.14 Takeda
6.14.1 Takeda Corporation Information
6.14.2 Takeda Bromhexine Description and Business Overview
6.14.3 Takeda Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Takeda Bromhexine Product Portfolio
6.14.5 Takeda Recent Developments/Updates
6.15 Shanghai Xudong Haipu Pharmaceutical
6.15.1 Shanghai Xudong Haipu Pharmaceutical Corporation Information
6.15.2 Shanghai Xudong Haipu Pharmaceutical Bromhexine Description and Business Overview
6.15.3 Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shanghai Xudong Haipu Pharmaceutical Bromhexine Product Portfolio
6.15.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments/Updates
6.16 Jincheng Haisi Pharmaceutical
6.16.1 Jincheng Haisi Pharmaceutical Corporation Information
6.16.2 Jincheng Haisi Pharmaceutical Bromhexine Description and Business Overview
6.16.3 Jincheng Haisi Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Jincheng Haisi Pharmaceutical Bromhexine Product Portfolio
6.16.5 Jincheng Haisi Pharmaceutical Recent Developments/Updates
6.17 Shanxi Powerdone Pharmaceutical
6.17.1 Shanxi Powerdone Pharmaceutical Corporation Information
6.17.2 Shanxi Powerdone Pharmaceutical Bromhexine Description and Business Overview
6.17.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
6.17.5 Shanxi Powerdone Pharmaceutical Recent Developments/Updates
6.18 Shanxi Powerdone Pharmaceutical
6.18.1 Shanxi Powerdone Pharmaceutical Corporation Information
6.18.2 Shanxi Powerdone Pharmaceutical Bromhexine Description and Business Overview
6.18.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
6.18.5 Shanxi Powerdone Pharmaceutical Recent Developments/Updates
6.19 Wanbangde Pharmaceutical Group
6.19.1 Wanbangde Pharmaceutical Group Corporation Information
6.19.2 Wanbangde Pharmaceutical Group Bromhexine Description and Business Overview
6.19.3 Wanbangde Pharmaceutical Group Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Wanbangde Pharmaceutical Group Bromhexine Product Portfolio
6.19.5 Wanbangde Pharmaceutical Group Recent Developments/Updates
6.20 Shijiazhuang No.4 Pharmaceutical
6.20.1 Shijiazhuang No.4 Pharmaceutical Corporation Information
6.20.2 Shijiazhuang No.4 Pharmaceutical Bromhexine Description and Business Overview
6.20.3 Shijiazhuang No.4 Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Shijiazhuang No.4 Pharmaceutical Bromhexine Product Portfolio
6.20.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
6.21 Ma'AnShan BBCA Pharmaceutical
6.21.1 Ma'AnShan BBCA Pharmaceutical Corporation Information
6.21.2 Ma'AnShan BBCA Pharmaceutical Bromhexine Description and Business Overview
6.21.3 Ma'AnShan BBCA Pharmaceutical Bromhexine Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Ma'AnShan BBCA Pharmaceutical Bromhexine Product Portfolio
6.21.5 Ma'AnShan BBCA Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bromhexine Industry Chain Analysis
7.2 Bromhexine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bromhexine Production Mode & Process
7.4 Bromhexine Sales and Marketing
7.4.1 Bromhexine Sales Channels
7.4.2 Bromhexine Distributors
7.5 Bromhexine Customers
8 Bromhexine Market Dynamics
8.1 Bromhexine Industry Trends
8.2 Bromhexine Market Drivers
8.3 Bromhexine Market Challenges
8.4 Bromhexine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Bromhexine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Bromhexine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Bromhexine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Bromhexine Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Bromhexine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Bromhexine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Bromhexine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Bromhexine Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Bromhexine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Bromhexine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bromhexine, Product Type & Application
Table 12. Global Key Manufacturers of Bromhexine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bromhexine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bromhexine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bromhexine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Bromhexine Sales by Region (2018-2023) & (K MT)
Table 18. Global Bromhexine Sales Market Share by Region (2018-2023)
Table 19. Global Bromhexine Sales by Region (2024-2029) & (K MT)
Table 20. Global Bromhexine Sales Market Share by Region (2024-2029)
Table 21. Global Bromhexine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Bromhexine Revenue Market Share by Region (2018-2023)
Table 23. Global Bromhexine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Bromhexine Revenue Market Share by Region (2024-2029)
Table 25. North America Bromhexine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Bromhexine Sales by Country (2018-2023) & (K MT)
Table 27. North America Bromhexine Sales by Country (2024-2029) & (K MT)
Table 28. North America Bromhexine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Bromhexine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Bromhexine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Bromhexine Sales by Country (2018-2023) & (K MT)
Table 32. Europe Bromhexine Sales by Country (2024-2029) & (K MT)
Table 33. Europe Bromhexine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Bromhexine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Bromhexine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Bromhexine Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Bromhexine Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Bromhexine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Bromhexine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Bromhexine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Bromhexine Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Bromhexine Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Bromhexine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Bromhexine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Bromhexine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Bromhexine Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Bromhexine Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Bromhexine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Bromhexine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Bromhexine Sales (K MT) by Type (2018-2023)
Table 51. Global Bromhexine Sales (K MT) by Type (2024-2029)
Table 52. Global Bromhexine Sales Market Share by Type (2018-2023)
Table 53. Global Bromhexine Sales Market Share by Type (2024-2029)
Table 54. Global Bromhexine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Bromhexine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Bromhexine Revenue Market Share by Type (2018-2023)
Table 57. Global Bromhexine Revenue Market Share by Type (2024-2029)
Table 58. Global Bromhexine Price (USD/MT) by Type (2018-2023)
Table 59. Global Bromhexine Price (USD/MT) by Type (2024-2029)
Table 60. Global Bromhexine Sales (K MT) by Application (2018-2023)
Table 61. Global Bromhexine Sales (K MT) by Application (2024-2029)
Table 62. Global Bromhexine Sales Market Share by Application (2018-2023)
Table 63. Global Bromhexine Sales Market Share by Application (2024-2029)
Table 64. Global Bromhexine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Bromhexine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Bromhexine Revenue Market Share by Application (2018-2023)
Table 67. Global Bromhexine Revenue Market Share by Application (2024-2029)
Table 68. Global Bromhexine Price (USD/MT) by Application (2018-2023)
Table 69. Global Bromhexine Price (USD/MT) by Application (2024-2029)
Table 70. Sanofi Aventis Corporation Information
Table 71. Sanofi Aventis Description and Business Overview
Table 72. Sanofi Aventis Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. Sanofi Aventis Bromhexine Product
Table 74. Sanofi Aventis Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Teva Bromhexine Product
Table 79. Teva Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Boehringer Ingelheim Bromhexine Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Novartis Bromhexine Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Mylan Bromhexine Product
Table 94. Mylan Recent Developments/Updates
Table 95. Sanyo Chemical Laboratroy Corporation Information
Table 96. Sanyo Chemical Laboratroy Description and Business Overview
Table 97. Sanyo Chemical Laboratroy Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Sanyo Chemical Laboratroy Bromhexine Product
Table 99. Sanyo Chemical Laboratroy Recent Developments/Updates
Table 100. Sandoz Corporation Information
Table 101. Sandoz Description and Business Overview
Table 102. Sandoz Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Sandoz Bromhexine Product
Table 104. Sandoz Recent Developments/Updates
Table 105. LGM Pharma Corporation Information
Table 106. LGM Pharma Description and Business Overview
Table 107. LGM Pharma Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. LGM Pharma Bromhexine Product
Table 109. LGM Pharma Recent Developments/Updates
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. GSK Bromhexine Product
Table 114. GSK Recent Developments/Updates
Table 115. Mayne Pharma Corporation Information
Table 116. Mayne Pharma Description and Business Overview
Table 117. Mayne Pharma Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Mayne Pharma Bromhexine Product
Table 119. Mayne Pharma Recent Developments/Updates
Table 120. Sigma-Aldrich Corporation Information
Table 121. Sigma-Aldrich Description and Business Overview
Table 122. Sigma-Aldrich Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Sigma-Aldrich Bromhexine Product
Table 124. Sigma-Aldrich Recent Developments/Updates
Table 125. Abbott Corporation Information
Table 126. Abbott Description and Business Overview
Table 127. Abbott Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Abbott Bromhexine Product
Table 129. Abbott Recent Developments/Updates
Table 130. Shanghai Sine Tianping Pharmaceutical Corporation Information
Table 131. Shanghai Sine Tianping Pharmaceutical Description and Business Overview
Table 132. Shanghai Sine Tianping Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Shanghai Sine Tianping Pharmaceutical Bromhexine Product
Table 134. Shanghai Sine Tianping Pharmaceutical Recent Developments/Updates
Table 135. Takeda Corporation Information
Table 136. Takeda Description and Business Overview
Table 137. Takeda Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. Takeda Bromhexine Product
Table 139. Takeda Recent Developments/Updates
Table 140. Shanghai Xudong Haipu Pharmaceutical Corporation Information
Table 141. Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
Table 142. Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 143. Shanghai Xudong Haipu Pharmaceutical Bromhexine Product
Table 144. Shanghai Xudong Haipu Pharmaceutical Recent Developments/Updates
Table 145. Jincheng Haisi Pharmaceutical Corporation Information
Table 146. Jincheng Haisi Pharmaceutical Description and Business Overview
Table 147. Jincheng Haisi Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 148. Jincheng Haisi Pharmaceutical Bromhexine Product
Table 149. Jincheng Haisi Pharmaceutical Recent Developments/Updates
Table 150. Shanxi Powerdone Pharmaceutical Corporation Information
Table 151. Shanxi Powerdone Pharmaceutical Description and Business Overview
Table 152. Shanxi Powerdone Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 153. Shanxi Powerdone Pharmaceutical Bromhexine Product
Table 154. Shanxi Powerdone Pharmaceutical Recent Developments/Updates
Table 155. Shanxi Powerdone Pharmaceutical Corporation Information
Table 156. Shanxi Powerdone Pharmaceutical Description and Business Overview
Table 157. Shanxi Powerdone Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 158. Shanxi Powerdone Pharmaceutical Bromhexine Product
Table 159. Shanxi Powerdone Pharmaceutical Recent Developments/Updates
Table 160. Wanbangde Pharmaceutical Group Corporation Information
Table 161. Wanbangde Pharmaceutical Group Description and Business Overview
Table 162. Wanbangde Pharmaceutical Group Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 163. Wanbangde Pharmaceutical Group Bromhexine Product
Table 164. Wanbangde Pharmaceutical Group Recent Developments/Updates
Table 165. Shijiazhuang No.4 Pharmaceutical Corporation Information
Table 166. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
Table 167. Shijiazhuang No.4 Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 168. Shijiazhuang No.4 Pharmaceutical Bromhexine Product
Table 169. Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
Table 170. Ma'AnShan BBCA Pharmaceutical Corporation Information
Table 171. Ma'AnShan BBCA Pharmaceutical Description and Business Overview
Table 172. Ma'AnShan BBCA Pharmaceutical Bromhexine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 173. Ma'AnShan BBCA Pharmaceutical Bromhexine Product
Table 174. Ma'AnShan BBCA Pharmaceutical Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Bromhexine Distributors List
Table 178. Bromhexine Customers List
Table 179. Bromhexine Market Trends
Table 180. Bromhexine Market Drivers
Table 181. Bromhexine Market Challenges
Table 182. Bromhexine Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bromhexine
Figure 2. Global Bromhexine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Bromhexine Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Bromhexine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Bromhexine Market Share by Application in 2022 & 2029
Figure 8. Chronic Bronchitis
Figure 9. Asthma
Figure 10. Others
Figure 11. Global Bromhexine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Bromhexine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Bromhexine Sales (2018-2029) & (K MT)
Figure 14. Global Bromhexine Average Price (USD/MT) & (2018-2029)
Figure 15. Bromhexine Report Years Considered
Figure 16. Bromhexine Sales Share by Manufacturers in 2022
Figure 17. Global Bromhexine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Bromhexine Players: Market Share by Revenue in 2022
Figure 19. Bromhexine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Bromhexine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Bromhexine Sales Market Share by Country (2018-2029)
Figure 22. North America Bromhexine Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Bromhexine Sales Market Share by Country (2018-2029)
Figure 26. Europe Bromhexine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Bromhexine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Bromhexine Revenue Market Share by Region (2018-2029)
Figure 34. China Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Bromhexine Sales Market Share by Country (2018-2029)
Figure 45. Latin America Bromhexine Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Bromhexine Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Bromhexine Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Bromhexine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Bromhexine by Type (2018-2029)
Figure 55. Global Revenue Market Share of Bromhexine by Type (2018-2029)
Figure 56. Global Bromhexine Price (USD/MT) by Type (2018-2029)
Figure 57. Global Sales Market Share of Bromhexine by Application (2018-2029)
Figure 58. Global Revenue Market Share of Bromhexine by Application (2018-2029)
Figure 59. Global Bromhexine Price (USD/MT) by Application (2018-2029)
Figure 60. Bromhexine
  • Global Carbocisteine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Carbocisteine market size was valued at US$ 55 million in 2023. With growing demand in downstream market, the Carbocisteine is forecast to a readjusted size of US$ 76 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Carbocisteine market. Carbocisteine are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Bovine Respiratory Disease Treatment Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for......
  • Global Ambroxol Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 91
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ambroxol market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva - Bayer - Novartis - Mylan - Bidachem - Hanmi - Hexal Pharma - Sris Pharmaceuticals - Hubei Ocean Biotechnology - DM Pharma......
  • Global Carbocisteine Professional Survey Report 2023, Forecast to 2028
    Published: 23-Nov-2023        Price: US 3280 Onwards        Pages: 101
    Carbocisteine is a type of medicine called a mucolytic. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to de......
  • Global Carbocisteine Market Research Report 2023, Forecast to 2028
    Published: 23-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Carbocisteine is a type of medicine called a mucolytic. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to de......
  • Global Bovine Respiratory Disease Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Bovine Respiratory Disease Treatment market: According to our latest research, the global Bovine Respiratory Disease Treatment market looks promising in the next 5 years. As of 2022, the global Bovine Respiratory Disease Treatment market was estimated at USD 1748.69 million, and it's anticipated to reach USD 2423.79 million in 2028, with a CAGR of 5.59% during the forecast years. Bovine respiratory disease (BRD) is a multifactorial and complex diseas......
  • Respiratory Collaboration and Licensing Deals 2016-2023
    Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 200
    Respiratory Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the respiratory deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of respiratory deals from 2016 to 2023. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Understanding......
  • Global Drugs For Respiratory Syncytial Virus (Rsv) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Sep-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Drugs For Respiratory Syncytial Virus (Rsv) market: According to our latest research, the global Drugs For Respiratory Syncytial Virus (Rsv) market looks promising in the next 5 years. As of 2022, the global Drugs For Respiratory Syncytial Virus (Rsv) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and......
  • Global Ambroxol Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Sep-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Ambroxol market: According to our latest research, the global Ambroxol market looks promising in the next 5 years. As of 2022, the global Ambroxol market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Ambroxol market, with a systematical descriptio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs